CLINICAL TRANSLATIONAL CATALYST (CTC)

Regulatory Affairs Funding Scheme

Subsidise 50% of expenditure for preclinical/nonclinical activities for

• Therapeutics, up to HK$4 million
• Class III medical devices, up to HK$2.5 million
• De novo medical devices, up to HK$1 million
• Class II medical devices, up to HK$0.5 million

Clinical Trial Funding Scheme

Subsidise 50% of expenditure for clinical trials for therapeutics and medical devices, up to HK$8 million.

ARE YOU ELIGIBLE TO APPLY FOR CTC FINANCIAL SUPPORT?

You are eligible to apply for this highly selective programme if:

• You are an existing HKSTP tenant*
• You have at least 3 full-time staffs working at your leased premises at HKSTP
• You will remain as HKSTP tenant for the entire term of the funding scheme
• The project coordinator and project team are full-time employees of your company at HKSTP

* Companies which are not HKSTP tenants should first apply for tenancy

Enquiry

Providing access to scientific, clinical, technical and regulatory experts, as well as commercial partners, our Professional Network Support is available for catalysing the translation of novel and breakthrough biomedical technologies from pre-clinical to clinical development stage.  

Support available via the Professional Network

• Learn about the latest regulatory updates via webinars and workshops
• Connect with experts to understand the regulatory approval and clinical trial processes
• Establish your network of principal investigators, technical experts and commercial partners (e.g. CROs, CDMOs and CMOs)

ASK CTC! is a specialized HELPDESK designed to help biomedical companies to kick-start their translational journey towards regulatory submissions and clinical trials.

PARTNERS IN OUR PROFESSIONAL NETWORK

• CLINICAL TRIAL CENTRES
  

  
• CROs, CDMOs, CMOs
  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

  

On behalf of the Hong Kong clinical research community, the Clinical Translational Consortium is established to provide strategic thought and SUPPORT policy development for strengthening the clinical translation research environment.

Vision 

Establish Hong Kong as a leading clinical trial hub within the region. 

Mission 

Strengthen Hong Kong’s clinical trial environment by leveraging the combined strengths of Hong Kong and the rest of the Greater Bay Area.

 Goals 

• Provide strategic thoughts and implement ideas to strengthen local clinical research environment and enhance the competitiveness of Hong Kong as a clinical trial hub
• Build an information platform and provide the industry, academic, and public with compendious information about clinical trials in Hong Kong
• Promote Hong Kong as a clinical trial hub and attract national and overseas biomedical companies landing in Hong Kong 

Our Consortium Members